Implementation of Roche's 'Operational Excellence' Initiative Will Trim Nearly 5,000 Sales, Manufacturing and R&D Jobs

Roche characterized the anticipated restructuring plan as a pre-emptive strike and maintained that the integration of Genentech was successful and continuing apace.